LataMed AI Corp. (OTC: LMED), a digital health and artificial intelligence technology company, announced it has initiated an evaluation process to integrate installment-based healthcare payment capabilities through Cashea, a leading buy-now-pay-later platform in Venezuela. The proposed initiative aims to reduce upfront financial barriers for patients seeking private healthcare services within the LataMed AI ecosystem, potentially covering consultations, diagnostics, wellness programs, and other eligible offerings.
Management believes that improving payment accessibility could drive greater patient engagement, increase healthcare utilization, and strengthen platform adoption. By addressing affordability challenges, the company aims to solidify its position as a technology-enabled healthcare marketplace serving patients, providers, and partners across Latin America. The potential integration aligns with LataMed AI's broader strategy of combining artificial intelligence, telehealth infrastructure, care coordination tools, and digital payment solutions to create a scalable healthcare marketplace.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “We believe financial accessibility is a critical component of healthcare delivery. Our objective is to evaluate solutions that may help patients obtain timely medical care while simultaneously expanding the reach and utility of our healthcare ecosystem. We believe initiatives such as this have the potential to strengthen patient acquisition, improve engagement, and support long-term platform growth.”
The company has not entered into a definitive commercial agreement as of the release date. Completion of any integration remains subject to further commercial discussions, technical implementation requirements, regulatory review, and customary business conditions. LataMed AI intends to provide additional updates as material developments occur.
This strategic move comes as healthcare costs in emerging markets often pose significant barriers to access. The rise of fintech solutions like Cashea has enabled consumers to spread payments for goods and services, and applying this model to healthcare could enhance affordability for patients while driving consistent revenue for providers. For LataMed AI, which focuses on emerging markets including Venezuela, integrating Cashea may differentiate its platform and accelerate user acquisition.
The company's focus on telehealth infrastructure and AI-enabled solutions positions it to address gaps in healthcare delivery. By potentially adding installment payment options, LataMed AI could lower the point-of-care cost, encouraging more frequent use of its services. This could be particularly impactful in regions where out-of-pocket expenses are high and insurance coverage is limited.
However, the initiative remains in early evaluation stages. The company cautioned that forward-looking statements involve risks, including the ability to negotiate and implement payment integration arrangements, operational execution in emerging markets, and regulatory approvals. Investors are urged to review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov for a complete discussion of risks.
Additional information about LataMed AI is available at https://latamed.ai. The original press release can be accessed via NewMediaWire at www.newmediawire.com.
